(Total Views: 91)
Posted On: 09/06/2023 10:20:32 AM
Post# of 145174

Nascent Biotech Inc., $NBIO, an early-stage biotech with a pipeline now reaching phase 2 for the first time. The IP is in place. The FDA support is in place. And the stock is dirt cheap.
https://www.benzinga.com/pressreleases/23/09/...-potential
https://www.benzinga.com/pressreleases/23/09/...-potential

